Baxter

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Baxter 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BAX

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. 

CEO
Andrew P. Hider
CEOAndrew P. Hider
Employees
38,000
Employees38,000
Headquarters
Deerfield, Illinois
HeadquartersDeerfield, Illinois
Founded
1931
Founded1931
Employees
38,000
Employees38,000

BAX Key Statistics

Market cap
9.26B
Market cap9.26B
Price-Earnings ratio
-34.52
Price-Earnings ratio-34.52
Dividend yield
3.78%
Dividend yield3.78%
Average volume
10.77M
Average volume10.77M
High today
$18.12
High today$18.12
Low today
$17.78
Low today$17.78
Open price
$17.95
Open price$17.95
Volume
7.40M
Volume7.40M
52 Week high
$37.74
52 Week high$37.74
52 Week low
$17.47
52 Week low$17.47

Stock Snapshot

As of today, Baxter(BAX) shares are valued at $18.07. The company's market cap stands at 9.26B, with a P/E ratio of -34.52 and a dividend yield of 3.8%.

On 2025-11-09, Baxter(BAX) stock moved within a range of $17.78 to $18.12. With shares now at $18.07, the stock is trading +1.6% above its intraday low and -0.2% below the session's peak.

Trading volume for Baxter(BAX) stock has reached 7.4M, versus its average volume of 10.77M.

The stock's 52-week range extends from a low of $17.47 to a high of $37.74.

The stock's 52-week range extends from a low of $17.47 to a high of $37.74.

BAX News

Simply Wall St 3d
Baxter International: Assessing Valuation Following Lawsuits and Safety Concerns Around Novum IQ Pump

Baxter International (BAX) has landed in the spotlight after a series of class action lawsuits and regulatory scrutiny linked to safety concerns with its Novum...

Baxter International: Assessing Valuation Following Lawsuits and Safety Concerns Around Novum IQ Pump
Simply Wall St 4d
Why Baxter International Is Down 21.5% After Novum Infusion Pump Disruptions and Lawsuits

In late October 2025, Baxter International reported third-quarter results showing increased sales to US$2,835 million but shifted from a net profit last year to...

Why Baxter International Is Down 21.5% After Novum Infusion Pump Disruptions and Lawsuits
Simply Wall St 5d
How Attractive Is Baxter After a 21% Weekly Drop and Strategic Divestitures in 2025?

Ever wondered if Baxter International is trading for less than its true worth? You're not alone, and that's exactly what we're here to explore. The stock has b...

How Attractive Is Baxter After a 21% Weekly Drop and Strategic Divestitures in 2025?

Analyst ratings

70%

of 20 ratings
Buy
20%
Hold
70%
Sell
10%

People also own

Based on the portfolios of people who own BAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.